Andrographolide ameliorates hepatic steatosis by suppressing FATP2-mediated fatty acid uptake in mice with nonalcoholic fatty liver disease

ABSTRACT: Excessive intrahepatocellular lipid accumulation or steatosis is caused by abnormal lipid metabolism and a common character of nonalcoholic fatty liver disease (NAFLD), which may progress into cirrhosis and hepatocellular cancer. Andrographolide (Andro) is the primary active ingredient ext...

Descripción completa

Detalles Bibliográficos
Autores principales: Ran, Li-Sha, Wu, Ya-Zeng, Gan, Yi-Wen, Wang, Hong-Lian, Wu, Li-Juan, Zheng, Chun-Mei, Ming, Yao, Xiong, Ran, Li, Yong-Lin, Lei, Shi-Hang, Wang, Xue, Lao, Xiao-Qing, Zhang, Hong-Min, Wang, Li, Chen, Chen, Zhao, Chang-Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810587/
https://www.ncbi.nlm.nih.gov/pubmed/36115008
http://dx.doi.org/10.1007/s11418-022-01647-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810587/
https://www.ncbi.nlm.nih.gov/pubmed/36115008
http://dx.doi.org/10.1007/s11418-022-01647-w

Ejemplares similares